In 2019, the FDA recommended its most serious warning label for BIOCELL textured breast implants that academic studies linked to a type of cancer known as BIA-ALCL. Two years on from the warning, and a decade after this was discovered, the issue is still unsolved. Healthtech Founder Joan Melendez believes this risk could be mitigated[ Read More ]
Joan Melendez has over 25 years of experience with healthcare applications, specializing in perioperative, anesthesia, and trauma workflows. Melendez created the health tech company Xcelrate UDI to significantly improve patient safety with medical devices, implants, and vaccines at the point of care.